| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/20/2000 | WO2000021456A1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000005343A3 Cell expansion system for use in neural transplantation |
| 04/20/2000 | WO2000002999A3 Medium and matrix for long-term proliferation of cells |
| 04/20/2000 | WO1999057266A3 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 04/20/2000 | DE19848017A1 Episomally replicating vectors, useful in gene therapy, contain origins of replication and scaffold-matrix attached region sequences but no viral coding sequences |
| 04/20/2000 | CA2346713A1 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | CA2346155A1 Enzymatic synthesis of ssdna |
| 04/20/2000 | CA2345900A1 Selectively replicating viral vectors |
| 04/20/2000 | CA2345885A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | CA2345211A1 Recombinant e1a deleted adenoviral vectors |
| 04/20/2000 | CA2314004A1 Matrix-remodeling genes |
| 04/19/2000 | EP0994185A2 Method for culturing Langerhans islets cells |
| 04/19/2000 | EP0993305A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 04/19/2000 | CN1251130A Isolated viable parasate intestinal cells |
| 04/19/2000 | CN1251047A Process for stimulating neural regeneration |
| 04/19/2000 | CN1250780A Shark liver irritant for preventing and curing hepatism and its preparing process |
| 04/19/2000 | CN1250665A Medicine for treating constipation and its preparing process |
| 04/19/2000 | CN1250662A Medicine 'Maikang' for treating vasculitis |
| 04/19/2000 | CN1250602A Health-care traditional Chinese medicine canned scorpion |
| 04/19/2000 | CN1051469C Traditional Chinese medicine capsule for treating habitual constipation |
| 04/19/2000 | CN1051462C Medicine for treating encephalatrophy |
| 04/19/2000 | CN1051461C Medicine 'Zhengxiesan' for treating facial paralysis and its prepn. method |
| 04/19/2000 | CN1051460C Method for treatment of leukoderma and its preparing method |
| 04/19/2000 | CN1051458C Medicine for treating bone and joint diseases and method for preparing same |
| 04/19/2000 | CN1051457C Medicine for rheumatic arthritis and its prepn. method |
| 04/19/2000 | CN1051456C Process for preparing nerve growth factor |
| 04/19/2000 | CN1051455C Liquid medicine for curing burn of scald and prepn. method thereof |
| 04/18/2000 | US6051613 Nitrogen monoxide production suppressor |
| 04/18/2000 | US6051552 Biosurfactant; prevent urogenital infections |
| 04/18/2000 | US6051432 Kit for producing autologous effector cells from extracts of human blood; includes apparatus for cell washing, culture, and purification and reagents like granulocyte-macrophage colony stimulating factor for culture and differentiation |
| 04/18/2000 | US6051402 A nucleic acid encoding an anti-sickling beta-globin protein; gene therapy for sickle cell |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051219 Method for reducing malodor with Bacillus subtilis Kubota |
| 04/18/2000 | US6051147 Methods for on line finishing of cellular blood products like platelets harvested for therapeutic purposes |
| 04/18/2000 | US6051146 Fluidizing a bed of first particles in carrier liquid to retain second particles within a rotating fluid chamber, diluting with lower density liquid to reduce overall density of separated particles and control coriolis force jetting |
| 04/18/2000 | CA2198607C Cell separation apparatus and method |
| 04/17/2000 | CA2286530A1 Method for culturing langerhans islets and islet autotransplantation islet regeneration |
| 04/17/2000 | CA2284849A1 Episomally replicating vector, its preparation and use |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020570A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/13/2000 | WO2000020560A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020433A1 Cytotoxic agents for the selective killing of lymphoma and leukemia cells and methods of use thereof |
| 04/13/2000 | WO2000020411A1 Cytotoxic alkaloids (halitulin) |
| 04/13/2000 | WO2000020053A1 Biological fluid filter and system |
| 04/13/2000 | WO2000020052A1 Device and method for perfusing peritoneal dialyzing fluid |
| 04/13/2000 | WO2000020041A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000020029A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | WO2000020013A1 Reduction of oxidative stress factors |
| 04/13/2000 | WO2000000588A3 Porcine spinal cord cells and their use in spinal cord repair |
| 04/13/2000 | WO1999064565A9 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 04/13/2000 | WO1999062451A9 Topical transdermal treatments |
| 04/13/2000 | WO1999055345A9 Combination viral-based and gene-based therapy of tumors |
| 04/13/2000 | CA2346865A1 Cytotoxic alkaloids (halitulin) |
| 04/13/2000 | CA2346369A1 Device and method for perfusing peritoneal dialyzing fluid |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2345535A1 Biological fluid filter and system |
| 04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 04/13/2000 | CA2345110A1 Reduction of oxidative stress factors |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 04/12/2000 | EP0991474A1 A carrier for holding a flexible fluid processing container |
| 04/12/2000 | EP0991416A1 A universally applicable blood plasma |
| 04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
| 04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250375A Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
| 04/12/2000 | CN1249947A Compound hemostatic |
| 04/12/2000 | CN1249942A Health oral liquid and its preparation |
| 04/12/2000 | CN1249941A Oral Chinese medicine liquid for treating tumor |
| 04/12/2000 | CN1249936A Health food capable of returning youthful vigour |
| 04/12/2000 | CN1249935A Preparation of collagenous fiber tissue for animal's organs and blood vessels |
| 04/12/2000 | CN1249901A Preparation of biochemical pesticide for preventing and killing water flea |
| 04/12/2000 | CN1051237C Medicine for treating epiplepsy |
| 04/12/2000 | CN1051236C 止血散 Hemostatic Powder |
| 04/12/2000 | CN1051234C Medicine for treating tuberculosis |
| 04/12/2000 | CN1051233C Plaster for treatment of tuberculosis for external use |
| 04/12/2000 | CN1051232C Chinese traditional medicine pills for treating dysphagia |
| 04/12/2000 | CN1051229C Preparation method of active dried earthworm powder |
| 04/11/2000 | US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048686 Hyperthermia and immunotherapy for cancer |
| 04/11/2000 | US6048566 Ubiquinone q10 and a polysorbate solubilizer in a nonalcoholic clear liquid. |
| 04/11/2000 | US6048525 Implanting hematopoietic cells comprising t-lymphocyte with dna sequence that expresses thymidine kinase gene; administering ganciclovir or acyclovir; treating graft versus host disease |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/11/2000 | US6048464 Filter medium for leukocyte removal, method of making, and method of using thereof |
| 04/06/2000 | WO2000018969A1 Methods to selectively inactivate viruses in biological compositions |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression |
| 04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |